ProShare Advisors’s Agilon Health AGL Stock Holding History

ProShare Advisors’s Portfolio AGL Stock Details AGL Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-2,251	Closed	-$38.7K	–	1869
2025 Q4	$38.7K	Buy	2,251 +140	+7%	+$2.71K	﹤0.01%	1976
2025 Q3	$54.4K	Sell	2,111 -421	-17%	-$15.9K	﹤0.01%	1926
2025 Q2	$146K	Sell	2,532 -139	-5%	-$11.1K	﹤0.01%	1795
2025 Q1	$289K	Sell	2,671 -804	-23%	-$70K	﹤0.01%	1439
2024 Q4	$165K	Buy	3,475 +1,143	+49%	+$69.1K	﹤0.01%	1944
2024 Q3	$229K	Buy	+2,332	New	+$301K	﹤0.01%	1651

Other funds holding AGL

CDR

Clayton Dubilier & Rice New York $895M AUM 792.56% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

NPCM

North Peak Capital Management New York $900M AUM 193.67% 1-Year Est. Return

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return

Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return

ProShare Advisors's AGL Position: Q1 2026 in Review

ProShare Advisors sold out of Agilon Health (AGL) in Q1 2026, closing a stake of 2,251 shares — an estimated $38.7K sold.

ProShare Advisors first reported a position in AGL in Q3 2024 and held it in 6 quarters. The position peaked at $289K in Q1 2025. 97 funds tracked by Wall St. Rank hold AGL as of Q1 2026.

ProShare Advisors reported no remaining Agilon Health position as of Q1 2026 after selling out during the quarter.
ProShare Advisors sold 2,251 Agilon Health shares in Q1 2026, an estimated $38.7K.
ProShare Advisors first reported a position in Agilon Health in Q3 2024 and held it in 6 quarters.
ProShare Advisors's Agilon Health position peaked at $289K in Q1 2025.
97 funds tracked by Wall St. Rank held Agilon Health as of Q1 2026.

Based on ProShare Advisors's 13F filing for Q1 2026, filed 27 Apr 2026.